Primary tongue leiomyosarcoma.

BMJ Case RepOct 1, 2026 (epub)

Atul Kumar Gupta, Bharti Devnani, Dharma Ram Poonia et al.

✦ AI-curated · Sources linked

Case in brief

A male patient in his mid 50s presented with a non-healing ulcer on the right lateral border of the tongue, accompanied by impaired tongue movement. Histopathological examination confirmed a diagnosis of leiomyosarcoma (LMS) of the tongue. The patient underwent surgical excision, followed by radiotherapy and chemotherapy due to the advanced stage and high-grade features. At 8 months post-treatment, he remains disease-free with no signs of recurrence.

What made this case unusual

Tongue leiomyosarcoma is extremely rare, constituting a very small percentage of oral malignancies, making this case noteworthy.

Diagnostic / clinical pearl

Clinicians should consider leiomyosarcoma in the differential diagnosis of non-healing oral ulcers, especially when accompanied by functional impairment.

Why it matters

This case underscores the necessity of a multi-disciplinary approach in managing rare malignancies like tongue LMS, integrating both surgical and systemic therapies.

Source

Published in BMJ Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.